[Metformin--its regimen and effects].
Shiba
Teruo
T
Division of Internal Medicine, Mitsui Memorial Hospital.
D020909:Acarbose / Q000008:administration & dosage; D001645:Biguanides / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D003510:Cyclohexanes / Q000008:administration & dosage; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D007328:Insulin / Q000008:administration & dosage; D008687:Metformin / Q000008:administration & dosage*; D000077715:Nateglinide; D018579:Patient Selection; D010649:Phenylalanine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D013453:Sulfonylurea Compounds / Q000008:administration & dosage; D016896:Treatment Outcome
D001645:Biguanides; D003510:Cyclohexanes; D007004:Hypoglycemic Agents; D007328:Insulin; D013453:Sulfonylurea Compounds; D000077715:Nateglinide; D010649:Phenylalanine; D008687:Metformin; D020909:Acarbose